Alumis ALMS
NASDAQ ALMS
$7.30 +0.01 (+0.14%)
As of: Sep 30, 2026 · 3:06 PM EDT

Alumis (ALMS) Revenue (2025 - 2026)

Updated

Alumis (ALMS) recorded Revenue of $1.66 million in Q2 2026, down 37.7% from $2.67 million a year earlier.

Analysis

Alumis (ALMS) Revenue (2025 - 2026) Analysis & Trends

On a TTM basis, Alumis' Revenue came in at $8.32 million as of Jun 30, 2026; for FY2025, it came in at $24.05 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Alumis 907.21 Mn -767.63 Mn - 1.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.66 Mn
Dec 31, 2025 1.93 Mn
Sep 30, 2025 2.07 Mn
Jun 30, 2025 2.67 Mn
Mar 31, 2025 17.40 Mn
API Access

Alumis Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ALMS&period=max&api_key=YOUR_API_KEY